254 related articles for article (PubMed ID: 30214638)
1. Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction.
Tang TT; Li YY; Li JJ; Wang K; Han Y; Dong WY; Zhu ZF; Xia N; Nie SF; Zhang M; Zeng ZP; Lv BJ; Jiao J; Liu H; Xian ZS; Yang XP; Hu Y; Liao YH; Wang Q; Tu X; Mallat Z; Huang Y; Shi GP; Cheng X
Theranostics; 2018; 8(16):4552-4562. PubMed ID: 30214638
[TBL] [Abstract][Full Text] [Related]
2. An IL-6/STAT3/MR/FGF21 axis mediates heart-liver cross-talk after myocardial infarction.
Sun JY; Du LJ; Shi XR; Zhang YY; Liu Y; Wang YL; Chen BY; Liu T; Zhu H; Liu Y; Ruan CC; Gan Z; Ying H; Yin Z; Gao PJ; Yan X; Li RG; Duan SZ
Sci Adv; 2023 Apr; 9(14):eade4110. PubMed ID: 37018396
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling.
Eid RA; Alkhateeb MA; Eleawa S; Al-Hashem FH; Al-Shraim M; El-Kott AF; Zaki MSA; Dallak MA; Aldera H
Basic Res Cardiol; 2018 Feb; 113(2):13. PubMed ID: 29392420
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1α dependent survival of cardiac fibroblasts is associated with StAR/STARD1 expression and improved cardiac remodeling and function after myocardial infarction.
Razin T; Melamed-Book N; Argaman J; Galin I; Lowy Y; Anuka E; Naftali-Shani N; Kandel-Kfir M; Garfinkel BP; Brielle S; Granot Z; Apte RN; Conway SJ; Molkentin JD; Kamari Y; Leor J; Orly J
J Mol Cell Cardiol; 2021 Jun; 155():125-137. PubMed ID: 33130150
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction.
Xu JY; Xiong YY; Tang RJ; Jiang WY; Ning Y; Gong ZT; Huang PS; Chen GH; Xu J; Wu CX; Hu MJ; Xu J; Xu Y; Huang CR; Jin C; Lu XT; Qian HY; Li XD; Yang YJ
Cardiovasc Res; 2022 Jul; 118(9):2165-2178. PubMed ID: 34259869
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction.
Bageghni SA; Hemmings KE; Yuldasheva NY; Maqbool A; Gamboa-Esteves FO; Humphreys NE; Jackson MS; Denton CP; Francis S; Porter KE; Ainscough JF; Pinteaux E; Drinkhill MJ; Turner NA
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393855
[TBL] [Abstract][Full Text] [Related]
8. Chemokine CCL2 promotes cardiac regeneration and repair in myocardial infarction mice via activation of the JNK/STAT3 axis.
Wang W; Chen XK; Zhou L; Wang F; He YJ; Lu BJ; Hu ZG; Li ZX; Xia XW; Wang WE; Zeng CY; Li LP
Acta Pharmacol Sin; 2024 Apr; 45(4):728-737. PubMed ID: 38086898
[TBL] [Abstract][Full Text] [Related]
9. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.
Ghali R; Habeichi NJ; Kaplan A; Tannous C; Abidi E; Bekdash A; Farhat R; Itani H; Jurjus A; Booz GW; Mallat Z; Zouein FA
Clin Sci (Lond); 2020 Jun; 134(11):1191-1218. PubMed ID: 32432676
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
[TBL] [Abstract][Full Text] [Related]
11. Wild-type p53-induced Phosphatase 1 Deficiency Exacerbates Myocardial Infarction-induced Ischemic Injury.
Liu KM; Zhang HH; Wang YN; Wang LM; Chen HY; Long CF; Zhang LF; Zhang HB; Yan HB
Chin Med J (Engl); 2017 Jun; 130(11):1333-1341. PubMed ID: 28524834
[TBL] [Abstract][Full Text] [Related]
12. Iron Regulator Hepcidin Impairs Macrophage-Dependent Cardiac Repair After Injury.
Zlatanova I; Pinto C; Bonnin P; Mathieu JRR; Bakker W; Vilar J; Lemitre M; Voehringer D; Vaulont S; Peyssonnaux C; Silvestre JS
Circulation; 2019 Mar; 139(12):1530-1547. PubMed ID: 30586758
[TBL] [Abstract][Full Text] [Related]
13. IL-17A promotes ventricular remodeling after myocardial infarction.
Zhou SF; Yuan J; Liao MY; Xia N; Tang TT; Li JJ; Jiao J; Dong WY; Nie SF; Zhu ZF; Zhang WC; Lv BJ; Xiao H; Wang Q; Tu X; Liao YH; Shi GP; Cheng X
J Mol Med (Berl); 2014 Oct; 92(10):1105-16. PubMed ID: 24965614
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.
Krishnamurthy P; Thal M; Verma S; Hoxha E; Lambers E; Ramirez V; Qin G; Losordo D; Kishore R
Circ Res; 2011 Nov; 109(11):1280-9. PubMed ID: 21959218
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific ablation of the STAT3 gene in the subacute phase of myocardial infarction exacerbated cardiac remodeling.
Enomoto D; Obana M; Miyawaki A; Maeda M; Nakayama H; Fujio Y
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(3):H471-80. PubMed ID: 26055795
[TBL] [Abstract][Full Text] [Related]
17. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
Shirakawa K; Endo J; Kataoka M; Katsumata Y; Yoshida N; Yamamoto T; Isobe S; Moriyama H; Goto S; Kitakata H; Hiraide T; Fukuda K; Sano M
Circulation; 2018 Oct; 138(18):2021-2035. PubMed ID: 29967195
[TBL] [Abstract][Full Text] [Related]
18. Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction.
An W; Yu Y; Zhang Y; Zhang Z; Yu Y; Zhao X
Br J Pharmacol; 2019 Mar; 176(5):699-710. PubMed ID: 30460984
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-22 Directly Activates Myocardial STAT3 (Signal Transducer and Activator of Transcription-3) Signaling Pathway and Prevents Myocardial Ischemia Reperfusion Injury.
Takahashi J; Yamamoto M; Yasukawa H; Nohara S; Nagata T; Shimozono K; Yanai T; Sasaki T; Okabe K; Shibata T; Mawatari K; Kakuma T; Aoki H; Fukumoto Y
J Am Heart Assoc; 2020 Apr; 9(8):e014814. PubMed ID: 32301368
[TBL] [Abstract][Full Text] [Related]
20. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
